abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Artículo

21 May 2019

Autor:
Joanna Walters, Guardian (UK)

USA: Painkiller maker Purdue Pharma sued by 5 additional states over alleged misconduct in opioids marketing & sales

"Five more US states sue Purdue Pharma over its role in opioid crisis"

Five more US states sued the painkiller maker Purdue Pharma on Thursday, alleging misconduct in the marketing and sales of opioids such as the company’s highly profitable OxyContin narcotic.

Wisconsin, Iowa, Kansas, Maryland and West Virginia filed separate but similar lawsuits, bringing the number of states suing the pharmaceutical company to 45, over its alleged role in the US opioids crisis that has caused thousands of drug overdose deaths. Pennsylvania sued the company two days ago, while New York’s Metropolitan Museum of Art on Wednesday joined a host of cultural and academic institutions in announcing it would stop accepting philanthropy from the Sackler family members behind Purdue Pharma...

The five states that filed on Thursday are also suing Richard Sackler, who was previously Purdue’s co-chairman and president and is one of the leading members of the Sackler family who wholly own the private company...

Sackler has been sued in several other such lawsuits in recent months and Purdue is also being sued by more than 1,500 cities and counties from all across the US.

West Virginia’s lawsuit alleges Purdue Pharma aggressively pushed false claims and deceptive practices, even in the past training new marketing employees with the advertising motto: “We sell hope in a bottle.”

“This lawsuit reveals many years of painstaking investigation,” West Virginia’s attorney general, Patrick Morrisey, said. “The senseless death and ruined lives of untold thousands must stop.”...

Parte de las siguientes historias

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors

Información de privacidad

Este sitio usa cookies y otras tecnologías de almacenamiento web. Puede configurar sus preferencias de privacidad más adelante. Los cambios se aplicarán de inmediato.

Para más información sobre el uso que hacemos del almacenamiento web, por favor consulte nuestra Política de Cookies y Uso de Datos

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Cookies analíticas

ON
OFF

Cuando accede a nuestro sitio web, utilizamos Google Analytics para recopilar información sobre su visita. La aceptación de esta cookie nos permitirá conocer más detalles sobre su visita y mejorar la forma en que mostramos la información. Toda la información analítica es anónima y no la utilizamos para identificarle. Google proporciona un complemento de inhabilitación de Google Analytics para todos los navegadores populares.

Cookies promocionales

ON
OFF

Compartimos noticias y actualizaciones sobre empresas y derechos humanos a través de plataformas de terceros, incluidas las redes sociales y los motores de búsqueda. Estas cookies nos ayudan a comprender el rendimiento de estas promociones.

Sus preferencias de privacidad en este sitio

Este sitio usa cookies y otras tecnologías de almacenamiento web para mejorar su experiencia, mas allá de la funcionalidad básica necesaria.